Online Media Kit
FEATURED STORY
March 16, 2022 | Times LIVE (South Africa)
The South African Health Products Regulatory Authority (SAHPRA) okayed the use of the monthly dapivirine vaginal ring by adult women.
FEATURED STORY
February 26, 2022 | The East African (Kenya)
Given a choice between two HIV prevention products, most adolescent girls and young women who had used both products while participating in the REACH study chose the monthly dapivirine ring.
FEATURED STORY
January 26, 2021 | World Health Organization
WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as...
Media Highlights
March 16, 2022 | Times LIVE (South Africa)
The South African Health Products Regulatory Authority (SAHPRA) okayed the use of the monthly dapivirine vaginal ring by adult women.
March 15, 2022 | Health-e News (South Africa)
Dapivirine vaginal ring: SA rollout put on ice for now
The Department of Health will review the clinical indicators and the implementation requirements approved by SAHPRA, and work with partners to implement the product at selected facilities, said a...
March 15, 2022 | Business Day (South Africa)
The ring is the first of a new generation of less frequently dosed interventions for HIV prevention.
March 11, 2022 | AVAC
AVAC's statement supports the ring's addition to the HIV prevention method mix.
March 11, 2022 | Johnson & Johnson
The dapivirine ring is the first long-acting HIV prevention option designed specifically for women. 51²è¹Ý¶ù developed the dapivirine ring through an exclusive...